Guidelines for Authors
www.karger.com/drm_guidelines
 Submission
Conditions
Sections
Topics
Conflicts of Interest
Ethics
Rapid Communication/Hot Topics
Arrangement
Color Illustrations
Anonymity in Case Reports
References
Digital Object Identifier (DOI)
Author's ChoiceTM, NIH-Funded Research, Self-Archiving
Page Charges
Proofs
Reprints
Submission
Only original papers written in English should be submitted online:
Should you experience any problems with your submission, please contact:
drm@karger.ch
Editorial Office 'Dermatology'
S. Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1356
Fax +41 61 306 1434
Conditions
All manuscripts are subject to editorial review.
Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Dermatology'and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Sections
The journal consists of the following sections:
Editorials
Original Papers
Case & Review (This section contains case reports extended with
literature reviews)
Case Reports
Letters
We proudly publish the Newsletter of the International League of Dermatological Societies (ILDS).
Topics
Please submit papers of the following topics:
Clinical and Laboratory Studies
Dermatopathology
Dermatosurgery and Related Interventional Techniques
Imaging Techniques
Evidence-Based Dermatology
Pharmacology and Treatment
Conflicts of Interest
Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.
Ethics
Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute’s committee on human research. Further, they should also state that animal experiments conform to institutional standards.
Rapid Communications / Hot Topics
Authors may apply to have their paper treated as a rapid communication. Condition for this is a brief definite report of important results. Final decision whether a paper will be published as a rapid communication will be made by the Editors. A publication time of three months after acceptance is intended.
Arrangement
Papers should comprise approximately 13 pages including figures, tables and references. For technical details please refer to the Technical Instructions.
Title page: The first page of each paper should indicate the title, the authors’ names, the institute where the work was conducted, and a short title for use as running head.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).
Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: For indexing purposes, a list of 3–10 key words in English is essential for all papers.
Abstract: Normally each paper needs an abstract of not more than 150 words. It should contain the following information: purpose of the study, procedures, results, conclusions and message of the paper.
Abstracts submitted for publication in the section Original Papers should be structured as follows:
Background: What is the major problem that prompted the study?
Objective: What is the purpose of the study?
Methods: How was the study performed?
Results: Most important findings?
Conclusion: Most important conclusion?
Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.
Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be stored in separate files. Tables require a heading and figures a legend, also prepared in a separate file.
When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. For further details please refer to the technical Instructions.
Color Illustrations
During the review process, the decision will be made as to which color illustrations of a manuscript can be reproduced free of charge. Authors will be informed of this at the time of acceptance of their paper. Otherwise, these illustrations will be reproduced at the author's expense. Up to 6 color illustrations per page can be integrated into the text at the special price of CHF 760.00 per page.
Anonymity in Case Reports
Authors should preserve patients' anonymity both in the text and figures, in the case that patients might be identified, authors should obtain his (her) informed consent.
References
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text.
Avoid using abstracts and posters as references. If necessary, list as footnotes in standard reference format, followed by the designation '(abstr.)' or '(poster)' For posters, add the details of the meeting where presented.
Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997;336:309–315. www.icmje.org)
|
Examples
(a) Papers published in periodicals:
Chatel JM, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:
14–18.
(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 3, revised. Basel, Karger, 1996.
(d) Edited books:
DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137.
|
Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
Author's ChoiceTM
Karger's Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com. The option is available for a one-time fee of CHF 2,750.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
NIH-Funded Research
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author's ChoiceTM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH's Public Access Policy is available here.
Self-Archiving
Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's Author's ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links.
Page Charges
There are no page charges for papers of 4 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 310.00. The allotted size of a paper is equal to approx. 13 manuscript pages (including tables, illustrations and references).
Proofs
Unless indicated otherwise, proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author. No page proofs are supplied.
Reprints
Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.
|
|
|
| Search in this journal
|
|
|
|
For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.
|
|
|
Online Manuscript Submission
Guidelines
